Experimental drug reverses synaptic loss in mouse models of Alzheimer's
A drug initially developed to treat schizophrenia may offer potential to revive cognitive function in dementia patients, a new Yale study finds.
Austinj Stoner Lashae Nicholson Xiaotiant Fang Allyx Therapuetics Joshua Spurrier Stephen Strittmatter
Source: yale.edu